The "collateral damage" of the war on COVID-19: impact of the pandemic on the care of epithelial ovarian cancer

被引:6
|
作者
Goenka, Luxitaa [1 ]
Anandaradje, Annuja [2 ]
Nakka, Tejaeswar [1 ]
Kayal, Smita [1 ]
Dubashi, Biswajit [1 ]
Chaturvedula, Latha [3 ]
Veena, Pampapati [3 ]
Durairaj, Jayalakshmi [3 ]
Penumadu, Prasanth [4 ]
Ganesan, Prasanth [1 ]
机构
[1] JIPMER, Dept Med Oncol, Dhanvantri Nagar 605006, Puducherry, India
[2] JIPMER, Dept Clin Pharmacol, Pondicherry, India
[3] JIPMER, Dept Obstet & Gynecol, Pondicherry, India
[4] JIPMER, Dept Surg Oncol, Pondicherry, India
关键词
COVID-19; pandemic; Epithelial ovarian cancer; Treatment delay; National lockdown; INDIA;
D O I
10.1007/s12032-021-01588-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The covid-19 pandemic has impacted the management of non-covid-19 illnesses. Epithelial ovarian cancer (EOC) requires long-duration multidisciplinary treatment. Teleconsultation and shared care are suggested solutions to mitigate the consequences of the pandemic. However, these may be challenging to implement among patients who come from the lower economic strata. We report the disastrous impact of the pandemic on the care of EOC by comparing patients who were treated during the pandemic with those treated in the previous year. We collected the following data from newly diagnosed patients with EOC: time from diagnosis to treatment, time for completion of planned chemotherapy, and proportion of patients completing various components of therapy (surgery and chemotherapy). Patients treated between January 2019 and September 2019 (Group 1: Pre-covid) were compared with those treated between January 2020 and December 2020 (Group 2: During covid pandemic). A total of 82 patients were registered [Group 1: 43(51%) Group 2: 39(49)]. The median time from diagnosis to start of treatment was longer in group 2 when compared to group 1 [31(23-58) days versus 17(11-30) days (p = 0.03)]. The proportion of patients who had surgery in group 2 was lower in comparison to group 1 [33(77%) versus 21(54%) (p = 0.02)]. Proportion of patients who underwent neoadjuvant (NACT) and surgery were fewer in group 2 in comparison to group 1 [9(33%) versus 18(64%) p = 0.002]. Among patients planned for adjuvant chemotherapy, the median time from diagnosis to treatment was longer in group 2 [28(17-45) days, group 1 versus 49(26-78) days, group 2 (p = 0.04)]. The treatment of patients with EOC was adversely impacted due to the COVID-19 pandemic. There was a compromise in the proportion of patients completing planned therapy. Even among those who completed the treatment, there were considerable delays when compared with the pre-covid period. The impact of these compromises on the outcomes will be known with longer follow-up.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] The “collateral damage” of the war on COVID-19: impact of the pandemic on the care of epithelial ovarian cancer
    Luxitaa Goenka
    Annuja Anandaradje
    Tejaeswar Nakka
    Smita Kayal
    Biswajit Dubashi
    Latha Chaturvedula
    Pampapati Veena
    Jayalakshmi Durairaj
    Prasanth Penumadu
    Prasanth Ganesan
    [J]. Medical Oncology, 2021, 38
  • [2] IMPACT OF THE COVID-19 PANDEMIC ON THE CARE OF PATIENTS WITH OVARIAN CANCER
    Oymans, Eline
    De Kroon, Cornelis
    Bart, Joost
    Nijman, Hans
    Van Der Aa, Maaike
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A127 - A127
  • [3] Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic
    Sud, A.
    Jones, M. E.
    Broggio, J.
    Loveday, C.
    Torr, B.
    Garrett, A.
    Nicol, D. L.
    Jhanji, S.
    Boyce, S. A.
    Gronthoud, F.
    Ward, P.
    Handy, J. M.
    Yousaf, N.
    Larkin, J.
    Suh, Y-E
    Scott, S.
    Pharoah, P. D. P.
    Swanton, C.
    Abbosh, C.
    Williams, M.
    Lyratzopoulos, G.
    Houlston, R.
    Turnbull, C.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 (08) : 1065 - 1074
  • [4] Collateral damage of COVID-19 pandemic: Delayed medical care
    Masroor, Saqib
    [J]. JOURNAL OF CARDIAC SURGERY, 2020, 35 (06) : 1345 - 1347
  • [5] COVID-19 Pandemic: Its Impact and Collateral Damage in India
    Sane, Vikrant
    Sane, Rashmi
    [J]. JOURNAL OF CRANIOFACIAL SURGERY, 2020, 31 (08) : E807 - E808
  • [6] Collateral damage of the Covid-19 pandemic in breast cancer screening
    Villasenor-Navarro, Yolanda
    Sollozo-Dupont, Isabel
    [J]. SALUD PUBLICA DE MEXICO, 2021, 63 (04): : 461 - 461
  • [7] An unusual collateral damage of COVID-19 pandemic
    Medas, Renato
    Coelho, Rosa
    Macedo, Guilherme
    [J]. GASTROINTESTINAL ENDOSCOPY, 2020, 92 (06) : 1261 - 1262
  • [8] Collateral damage: the impact of the COVID-19 pandemic on the care of a patient with tuberculous neuroretinitis in Lagos, Nigeria
    Abikoye, Temiloluwa Moyosoreoluwa
    [J]. PAN AFRICAN MEDICAL JOURNAL, 2020, 35 : 135
  • [9] Collateral damage of COVID-19 pandemic: The impact on a gynecologic surgery department
    Piketty, Jeanne
    Carbonnel, Marie
    Murtada, Rouba
    Revaux, Aurelie
    Asmar, Jennifer
    Favre-Inhofer, Angeline
    Ayoubi, Jean-Marc
    [J]. JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2022, 51 (01)
  • [10] The impact of the COVID-19 pandemic on cancer care
    Mike Richards
    Michael Anderson
    Paul Carter
    Benjamin L. Ebert
    Elias Mossialos
    [J]. Nature Cancer, 2020, 1 : 565 - 567